These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4661092)

  • 41. Chemoimmunotherapy increases the lymphocyte reactivity of melanoma patients.
    Berkelhammer J; Mastrangelo MJ; Bellet RE; Berd D; Prehn RT
    Eur J Cancer (1965); 1979 Feb; 15(2):197-204. PubMed ID: 436896
    [No Abstract]   [Full Text] [Related]  

  • 42. [The cellular immunity indices of patients with malignant melanoma using the viral immunomodulator rigvir].
    Glinkina LS; Bruvere RZh; Venskus DR; Garklava RR; Muceniece AJ
    Vopr Onkol; 1992; 38(5):540-7. PubMed ID: 1300752
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Unspecific immunological investigations in patients with malignant melanoma (author's transl)].
    Knopf B; Wätzig V
    Dermatol Monatsschr; 1982 Jan; 168(1):24-33. PubMed ID: 7044849
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunotherapy in patients with melanoma.
    Seiger HF; Shingleton WW; Metzgar RS; Buckley CE
    Ann Surg; 1973 Sep; 178(3):352-9. PubMed ID: 4269702
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunotherapy in malignant melanomaa.
    Homes EC; Morton DL; Eilber FR; Golub SE; Sulit HL
    Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The immune response in human malignant melanoma.
    Mackie RM
    Clin Exp Dermatol; 1976 Mar; 1(1):23-8. PubMed ID: 773575
    [No Abstract]   [Full Text] [Related]  

  • 47. [Immunology of malignant melanoma (author's transl)].
    Macher E; Sorg C; Seibert Er
    Langenbecks Arch Chir; 1976 Nov; 342():533-8. PubMed ID: 994670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer topics: immunology and cancer revisited.
    O'Brien PH
    J S C Med Assoc; 1974 Jul; 70(7):223-6. PubMed ID: 4603086
    [No Abstract]   [Full Text] [Related]  

  • 49. Immune response and non-specific immunotherapy in melanoma.
    El-Domeiri AA
    Ann R Coll Surg Engl; 1978 Mar; 60(2):117-20. PubMed ID: 637492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of intravenous phytohaemagglutinin in a patient with disseminated malignant melanoma: a clinical and immunological study.
    Lewis MG; Humble JG; Lee ES; Phillips TM
    Rev Eur Etud Clin Biol; 1971 Nov; 16(9):924-7. PubMed ID: 5168456
    [No Abstract]   [Full Text] [Related]  

  • 51. Vaccination and melanoma risk.
    Pfahlberg A; Botev IN; Kölmel KF; Gefeller O
    Int J Cancer; 2002 Nov; 102(1):96-7. PubMed ID: 12353240
    [No Abstract]   [Full Text] [Related]  

  • 52. Neuraminidase immunotherapy of tumors in man.
    Rosato FE; Brown AS; Miller EE; Rosato EF; Mullis WF; Johnson J; Moskovitz A
    Surg Gynecol Obstet; 1974 Nov; 139(5):675-82. PubMed ID: 4428323
    [No Abstract]   [Full Text] [Related]  

  • 53. Immunotherapy of malignant melanoma with vaccinia virus.
    Roenigk HH; Deodhar S; St Jacques R; Burdick K
    Arch Dermatol; 1974 May; 109(5):668-73. PubMed ID: 4828533
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunopathologic changes in patients with cutaneous malignant melanoma following intratumoral inoculation BCG: correlation with cell-mediated immunity.
    Lieberman R; Epstein W; Fudenberg HH
    Int J Cancer; 1974 Sep; 14(3):401-16. PubMed ID: 4617711
    [No Abstract]   [Full Text] [Related]  

  • 55. Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system.
    Kumar S; Taylor G; Steward JK; Waghe MA; Morris-Jones P
    Int J Cancer; 1973 Jul; 12(1):194-205. PubMed ID: 4364270
    [No Abstract]   [Full Text] [Related]  

  • 56. Cell-mediated immunity against malignant melanoma in monozygous twins.
    Nagel GA; St Arneault G; Holland JF; Kirkpatrick D; Kirkpatrick R
    Cancer Res; 1970 Jun; 30(6):1828-32. PubMed ID: 5466283
    [No Abstract]   [Full Text] [Related]  

  • 57. Malignant melanoma.
    Moore GE; Gerner RE
    Surg Gynecol Obstet; 1971 Mar; 132(3):427-36. PubMed ID: 5546295
    [No Abstract]   [Full Text] [Related]  

  • 58. Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,
    de Vries JE; Cornain S; Rumke P
    Int J Cancer; 1974 Oct; 14(4):427-34. PubMed ID: 4549213
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter: Malignant melanoma arising de novo within a B.C.G. scarification site.
    Lokich JJ
    Lancet; 1975 Feb; 1(7902):331-2. PubMed ID: 46469
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients.
    Thatcher N; Crowther D
    Dev Biol Stand; 1977 Apr 13-15; 38():449-53. PubMed ID: 608536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.